Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Vitae Pharmaceuticals, Inc (VTAE) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2017 SC 13G/A Cormorant Asset Management, LLC reports a 0% stake in Vitae Pharmaceuticals, Inc.
02/14/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/04/2016 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
10/31/2016 EFFECT Form EFFECT - Notice of Effectiveness
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
10/25/2016 POS AM Form POS AM - Post-Effective amendments for registration statement
10/25/2016 8-K Quarterly results
10/25/2016 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
10/25/2016 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
10/17/2016 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
10/11/2016 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
10/04/2016 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
09/26/2016 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
09/26/2016 SC TO-T Form SC TO-T - Tender offer statement by Third Party
09/21/2016 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
09/16/2016 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
09/14/2016 SC14D9C Form SC14D9C - Written communication relating to third party tender offer
09/14/2016 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
09/14/2016 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger by and between Allergan Holdco US, Inc., Augusta Merger Sub, Inc. and Vitae Pharmaceuticals, Inc.",
"Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic Conditions"
08/15/2016 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
08/04/2016 10-Q Quarterly Report for the period ended June 30, 2016
08/03/2016 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Vitae Pharmaceuticals Reports Second Quarter 2016 Operating and Financial Results",
"Presentation Slides Accompanying August 3, 2016 Vitae Pharmaceuticals Inc. Webcast"
07/27/2016 8-K Form 8-K - Current report
06/30/2016 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
06/30/2016 8-K Form 8-K - Current report
05/26/2016 8-K Submission of Matters to a Vote of Security Holders
05/10/2016 10-Q Quarterly Report for the period ended March 31, 2016
05/10/2016 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Vitae Pharmaceuticals Reports First Quarter 2016 Operating and Financial Results"
04/13/2016 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/13/2016 DEF 14A Form DEF 14A - Other definitive proxy statements
03/28/2016 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
03/25/2016 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy